Lifestyle Management App for Adults With Diabetes Type (LIVEN)

April 2, 2024 updated by: Shaima Alothman, Princess Nourah Bint Abdulrahman University

mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study

This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.

Study Overview

Detailed Description

This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Riyadh, Saudi Arabia, 11321
        • Recruiting
        • Princess Nourah bint Abdulrahman University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults, aged 18 years or older
  • Arabic speakers
  • Capable of utilizing smartphones
  • Diagnosed with T2DM
  • Poor glycemic control: A1c > 7.5%

Exclusion Criteria:

  • Individuals using insulin injection
  • Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)
  • Women who are pregnant or breastfeeding
  • Individuals diagnosed with other types of diabetes (such as type I or MODY)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: interactive mhealth Lifestyle behavior intervention
Receiving Standard care, LIVEN educational material and interactive LIVEN application
Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months
Sham Comparator: Sham group - app access only
Receiving standard care, LIVEN educational material and access to the application
Receiving standard care, LIVEN educational material and access to the application
No Intervention: Control group - Standard care
Receiving Standard care only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recruitment rate - descriptive
Time Frame: immediately after the intervention (3 months)
reported as the number of participants' consented divide by the number of people that were invited to participate
immediately after the intervention (3 months)
retention rates
Time Frame: immediately after the intervention (3 months)
reported as the number of participants completing all study sessions
immediately after the intervention (3 months)
User friendliness
Time Frame: Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.
will be assessed via user engagement tracking in the app
Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic control - A1c
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assess via A1c blood test will be reported as percentage. higher % indicate worse outcome
will be assessed one week prior to the intervention and one week after the end of the intervention
Glycemic control - continuous glucose mentoring (CGM)
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assess via continuous glucose mentoring (CGM) as variability. higher variability indicates worse outcome
will be assessed one week prior to the intervention and one week after the end of the intervention
Body composition - fat free mass (%) physiological parameter
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assessed via Bioelectrical Impedance Analysis (BIA). fat free mass (%) will reported as percentage. higher % indicate better outcome
will be assessed one week prior to the intervention and one week after the end of the intervention
Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assessed via Health-Promoting Lifestyle profile II. HPLP-II is a 4-point Likert scale with 52 items including six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships, and stress management. scores range from 52 to 208. higher scores indicate better outcome.
will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - upper body muscle strength in kg
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assessed via Hand Grip Strength using dynameter (power in kg), higher scores indicate higher physical performance
will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - lower body muscle strength in counts
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assessed via Sit to Stand Test (count), higher counts indicate higher physical performance
will be assessed one week prior to the intervention and one week after the end of the intervention
physical performance assessments - endurance
Time Frame: will be assessed one week prior to the intervention and one week after the end of the intervention
will be assessed via 6-minute walk test (distance in m). higher distance indicates higher endurance
will be assessed one week prior to the intervention and one week after the end of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 10, 2022

First Submitted That Met QC Criteria

November 18, 2022

First Posted (Actual)

November 29, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on interactive Mhealth Lifestyle behavior intervention

3
Subscribe